XML 15 R6.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Class A and Class B Common Stock
Additional Paid-in Capital
Additional Paid-in Capital
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Deficit
Accumulated Deficit
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive Income (Loss)
Beginning balance at Dec. 31, 2020 $ 1,676,163   $ 3 $ 8,977,061   $ (7,300,428)   $ (473)
Beginning balance (in shares) at Dec. 31, 2020     323,737          
Increase (Decrease) in Stockholders' Equity                
Issuance of common stock upon exercise of stock options 3,244     3,244        
Issuance of common stock upon exercise of stock options (in shares)     488          
Issuance of common stock upon settlement of restricted stock units (in shares)     5,218          
Shares withheld related to net share settlement (7,653)     (7,653)        
Shares withheld related to net share settlement (in shares)     (130)          
Stock-based compensation 164,229     164,229        
Other comprehensive income (loss) 218             218
Net loss (427,339)         (427,339)    
Ending balance at Mar. 31, 2021 1,408,862   $ 3 9,136,881   (7,727,767)   (255)
Ending balance (in shares) at Mar. 31, 2021     329,313          
Beginning balance at Dec. 31, 2020 1,676,163   $ 3 8,977,061   (7,300,428)   (473)
Beginning balance (in shares) at Dec. 31, 2020     323,737          
Increase (Decrease) in Stockholders' Equity                
Other comprehensive income (loss) (2,632)              
Net loss (778,971)              
Ending balance at Sep. 30, 2021 1,455,899   $ 3 9,538,400   (8,079,399)   (3,105)
Ending balance (in shares) at Sep. 30, 2021     340,720          
Beginning balance at Dec. 31, 2020 1,676,163   $ 3 8,977,061   (7,300,428)   (473)
Beginning balance (in shares) at Dec. 31, 2020     323,737          
Ending balance at Dec. 31, 2021 $ 1,341,213 $ (133,470) $ 3 9,706,293 $ (139,958) (8,362,572) $ 6,488 (2,511)
Ending balance (in shares) at Dec. 31, 2021     344,938          
Increase (Decrease) in Stockholders' Equity                
Accounting Standards Update [Extensible Enumeration] Accounting Standards Update 2020-06 [Member]              
Beginning balance at Mar. 31, 2021 $ 1,408,862   $ 3 9,136,881   (7,727,767)   (255)
Beginning balance (in shares) at Mar. 31, 2021     329,313          
Increase (Decrease) in Stockholders' Equity                
Issuance of common stock upon exercise of stock options 589     589        
Issuance of common stock upon exercise of stock options (in shares)     115          
Issuance of common stock upon settlement of restricted stock units (in shares)     5,279          
Shares withheld related to net share settlement (8,091)     (8,091)        
Shares withheld related to net share settlement (in shares)     (155)          
Issuance of common stock under employee stock purchase plan 16,559     16,559        
Issuance of common stock under employee stock purchase plan (in shares)     674          
Stock-based compensation 200,111     200,111        
Other comprehensive income (loss) (1,354)             (1,354)
Net loss (251,918)         (251,918)    
Ending balance at Jun. 30, 2021 1,364,758   $ 3 9,346,049   (7,979,685)   (1,609)
Ending balance (in shares) at Jun. 30, 2021     335,226          
Increase (Decrease) in Stockholders' Equity                
Issuance of common stock upon exercise of stock options 969     969        
Issuance of common stock upon exercise of stock options (in shares)     156          
Issuance of common stock upon settlement of restricted stock units (in shares)     5,469          
Shares withheld related to net share settlement (6,110)     (6,110)        
Shares withheld related to net share settlement (in shares)     (131)          
Settlement of convertible senior notes (1)     (1)        
Stock-based compensation 197,493     197,493        
Other comprehensive income (loss) (1,496)             (1,496)
Net loss (99,714)         (99,714)    
Ending balance at Sep. 30, 2021 1,455,899   $ 3 9,538,400   (8,079,399)   (3,105)
Ending balance (in shares) at Sep. 30, 2021     340,720          
Beginning balance at Dec. 31, 2021 1,341,213 (133,470) $ 3 9,706,293 (139,958) (8,362,572) 6,488 (2,511)
Beginning balance (in shares) at Dec. 31, 2021     344,938          
Increase (Decrease) in Stockholders' Equity                
Issuance of common stock upon exercise of stock options 90     90        
Issuance of common stock upon exercise of stock options (in shares)     65          
Issuance of common stock upon settlement of restricted stock units (in shares)     3,602          
Shares withheld related to net share settlement (1,807)     (1,807)        
Shares withheld related to net share settlement (in shares)     (44)          
Stock-based compensation 156,595     156,595        
Other comprehensive income (loss) (7,701)             (7,701)
Net loss (196,932)         (196,932)    
Ending balance at Mar. 31, 2022 1,157,988   $ 3 9,721,213   (8,553,016)   (10,212)
Ending balance (in shares) at Mar. 31, 2022     348,561          
Beginning balance at Dec. 31, 2021 1,341,213 $ (133,470) $ 3 9,706,293 $ (139,958) (8,362,572) $ 6,488 (2,511)
Beginning balance (in shares) at Dec. 31, 2021     344,938          
Increase (Decrease) in Stockholders' Equity                
Other comprehensive income (loss) (6,993)              
Net loss (996,379)              
Ending balance at Sep. 30, 2022 765,524   $ 4 10,127,487   (9,352,463)   (9,504)
Ending balance (in shares) at Sep. 30, 2022     360,931          
Beginning balance at Mar. 31, 2022 1,157,988   $ 3 9,721,213   (8,553,016)   (10,212)
Beginning balance (in shares) at Mar. 31, 2022     348,561          
Increase (Decrease) in Stockholders' Equity                
Issuance of common stock upon exercise of stock options 313     313        
Issuance of common stock upon exercise of stock options (in shares)     31          
Issuance of common stock upon settlement of restricted stock units 1   $ 1          
Issuance of common stock upon settlement of restricted stock units (in shares)     3,526          
Shares withheld related to net share settlement (1,742)     (1,742)        
Shares withheld related to net share settlement (in shares)     (90)          
Issuance of common stock under employee stock purchase plan 11,945     11,945        
Issuance of common stock under employee stock purchase plan (in shares)     703          
Stock-based compensation 176,644     176,644        
Other comprehensive income (loss) (776)             (776)
Net loss (377,246)         (377,246)    
Other 140     140        
Ending balance at Jun. 30, 2022 967,267   $ 4 9,908,513   (8,930,262)   (10,988)
Ending balance (in shares) at Jun. 30, 2022     352,731          
Increase (Decrease) in Stockholders' Equity                
Issuance of common stock upon exercise of stock options 47     47        
Issuance of common stock upon exercise of stock options (in shares)     15          
Issuance of common stock upon settlement of restricted stock units 0              
Issuance of common stock upon settlement of restricted stock units (in shares)     8,308          
Shares withheld related to net share settlement (2,053)     (2,053)        
Shares withheld related to net share settlement (in shares)     (123)          
Stock-based compensation 220,980     220,980        
Other comprehensive income (loss) 1,484             1,484
Net loss (422,201)         (422,201)    
Ending balance at Sep. 30, 2022 $ 765,524   $ 4 $ 10,127,487   $ (9,352,463)   $ (9,504)
Ending balance (in shares) at Sep. 30, 2022     360,931